By Robert Storace | May 17, 2017
The prescription drug company denied allegations that it falsely billed Medicaid and Medicare while agreeing to the settlement.
By Charles Toutant | May 3, 2017
AstraZeneca Pharmaceuticals and Bristol-Myers Squibb were hit with 14 suits in the District of New Jersey on Tuesday claiming that users of diabetes drug saxagliptin face elevated risks of heart failure as a result of using the drug.
By Amanda Bronstad | May 3, 2017
Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. and Bayer brought in powerhouse litigator Beth Wilkinson of Washington, D.C.'s Wilkinson Walsh + Eskovitz to lead the defense team in the first of four bellwether trials.
By Charles Toutant | May 2, 2017
A state appeals court tossed a $25 million verdict against Hoffmann-La Roche in a suit over acne drug Accutane after finding that the trial judge improperly restricted duplicative testimony from two defense experts.
By Jason Grant | May 1, 2017
A federal judge in Massachusetts ruled Manhattan plaintiffs firm Milberg "implemented an elaborate scheme of misrepresentation and deceit under the guise of a legitimate medical research study" and dismissed a plaintiff's qui tam action.
By P.J. D'Annunzio | May 1, 2017
There will be no second chance for a dismissed False Claims Act case pursued by a whistleblower and numerous government entities alleging that Genentech suppressed data about Avastin, a federal appeals court has decided.
By Charles Toutant | April 26, 2017
Already under scrutiny from lawmakers over pricing of its EpiPen epinephrine injector, Mylan faces new lawsuits from consumers and a competitor in New Jersey federal courts accusing it of taking anti-competitive actions to protect its product's market share.
By P.J. D'Annunzio | April 17, 2017
The Philadelphia judge did not explain his decision, but another lawsuit was tossed in December shortly after the defense started their case.
By Jenna Greene | April 16, 2017
Any litigator knows a case can rise or fall on the testimony of an expert witness. A New Jersey state judge made that abundantly clear when he skewered the plaintiffs' two experts in a long-running fight over the acne drug Accutane, banning their testimony and handing a huge win to Hoffman La Roche and Covington & Burling.
By Charles Toutant | April 13, 2017
Roxane Laboratories must pay legal fees and costs for two defendants after filing a patent infringement suit that was "exceptionally meritless," a federal judge in Newark has ruled.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...